Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Cogent Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.

Get COGT alerts

About Michael Yee

Michael Yee has spoken on 1 investor event across 1 company, most recently for Cogent Biosciences, Inc. on November 17, 2026. Cogent Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cogent Biosciences, Inc. includes Andrew Robbins (CEO and Board Member), Peter Harwin (Chairman and Board Member), John Green (CFO) and 7 others.

Michael Yee on recent calls

“And up here on the stage is Andrew Robbins, the President and CEO of Cogent. Thank you very much for being here. It's a pleasure to see you.”
Other, UBS Global Biopharma Conference London ·

Affiliation history

Company network

Leadership on record at Cogent Biosciences, Inc.

Recent activity